Preprint / Version 1

EVALUATION OF PRE-HOSPITAL PHARMACO-INVASE THERAPY FOR ACUTE MYOCARDIAL INFARCTION IN THE WESTERN REGION OF PARANÁ: EVALUATION OF PRE-HOSPITAL PHARMACO-INVASE THERAPY

##article.authors##

  • Marcio Allan De Souza Alves Federal University of Technology of Paraná image/svg+xml https://orcid.org/0000-0002-1090-1000
    • Giovana Fratin Secretaria de Saúde do Estado do Paraná
      • Gefferson Alexandre de Freitas Federal University of Technology of Paraná image/svg+xml
        • Vanessa Coldebella Secretaria de Saúde do Estado do Paraná
          • Amanda Silva Cardoso Secretaria de Saúde do Estado do Paraná
            • Angélica Maria Tortola Ribeiro Federal University of Technology of Paraná image/svg+xml
              • Leandra Ulbricht Federal University of Technology of Paraná image/svg+xml

                DOI:

                https://doi.org/10.1590/SciELOPreprints.11203

                Keywords:

                ST-Segment Elevation Myocardial Infarction, Tenecteplase, Pre-Hospital Emergency Management, Treatment Outcome, Health Management

                Abstract

                The objective was to analyze the pre-hospital pharmaco-invasive therapy strategy of the public health service in the western region of Paraná. This is a retrospective study based on data from the State Health Department (SESA-Pr) from December 2020 to November 2023. The mean age of the patients was 62 years (+/- 12.5), 62% were male, and 53.3% showed ST-segment resolution. The median time from diagnosis to thrombolysis was 119 minutes. Rescue catheterization was required in 29 (31.5%) patients. There were 8 (8.7%) deaths recorded within 30 days and 11 (12%) within 1 year. The low rate of ST-segment resolution, observed in only 53.3% of patients, was likely due to delays in the system, as 68.5% of patients received thrombolytics more than 90 minutes after diagnosis. It was concluded that the current model does not meet guideline recommendations and has room for improvement. It was recommended that SESA-PR change its strategy to extend pre-hospital fibrinolysis to Emergency Care Units (UPAs) and Small Hospitals, expanding the care network and reducing treatment delays.

                Downloads

                Download data is not yet available.

                Posted

                02/05/2025

                How to Cite

                EVALUATION OF PRE-HOSPITAL PHARMACO-INVASE THERAPY FOR ACUTE MYOCARDIAL INFARCTION IN THE WESTERN REGION OF PARANÁ: EVALUATION OF PRE-HOSPITAL PHARMACO-INVASE THERAPY: . (2025). In SciELO Preprints. https://doi.org/10.1590/SciELOPreprints.11203

                Section

                Health Sciences

                Plaudit

                Data statement

                • The research data is contained in the manuscript